OMRIX BIOPHARMACEUTICALS
Actief
0455.883.073 - 1831 Machelen (Brab.)
People administring OMRIX BIOPHARMACEUTICALS
| Name | Role / Mandate | Year |
|---|---|---|
| Bart Van Gompel | Vertegenwoordiger | 2019, 2018, 2017 |
| Beverly Pharaoh | Bestuurder | 2019, 2018, 2017 |
| Raf Uyttenbroeck | Bestuurder | 2017 |
| Wim Adriaenssen | Bestuurder | 2019 |
| Wim Adriaenssens | Bestuurder | 2018, 2017 |
Companies administring OMRIX BIOPHARMACEUTICALS
| Name | Enterprise # | Role | Year |
|---|---|---|---|
| Johnson & Johnson Inc | Moederonderneming | 2019, 2018, 2017 | |
| PricewaterhouseCoopers CVBA | 0429.501.944 | Commissaris | 2019 |
Companies that are administered by OMRIX BIOPHARMACEUTICALS
| Name | Enterprise # | Role | Year |
|---|---|---|---|
| No data available |
Companies holding participations in OMRIX BIOPHARMACEUTICALS
| Participations in | Value | Amount | % Direct | % Indirect | Type |
|---|---|---|---|
| No data available |
OMRIX BIOPHARMACEUTICALS has participations in
| Participations in | Value | Amount | % Direct | % Indirect | Type |
|---|---|---|---|
| No data available |